TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trialPol Specenier, Jan B. Vermorken, Cristiana Bergamini et al.|Annals of Oncology|2017Cited by 19
TPF plus cetuximab (E) induction chemotherapy (ICT) followed by biochemoradiation (BCRT) with weekly E plus weekly cisplatin (P) or carboplatin (C) in stage III/IV squamous cell carcinoma of the head and neck (HNSCC): A randomized phase II EORTC trial.Pol Specenier, Jan B. Vermorken, Éva Remenár et al.|Journal of Clinical Oncology|2016Cited by 1